Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 9Neoplasms 3Endometrial Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thrombocytopenia 1Stomach Neoplasms 1Solid Tumor, Adult 1Recurrence 1Rectal Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neutropenia 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Glioma 1Glioblastoma 1Fallopian Tube Neoplasms 1Cystadenocarcinoma, Serous 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Biliary Tract Neoplasms 1Astrocytoma 1

Interventions

Paclitaxel 2Carboplatin 2niraparib 1fludarabine 1Valganciclovir 1Radiotherapy 1Interleukin-2 1Docetaxel 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Solid Tumor, Adult × niraparib × Clear all
NCT03209401 2024-02-05

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

Georgetown University

Phase 1 Terminated
23 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡